AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15483465
Drug: Indinavir (IDV)/Ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir (IDV)/Ritonavir (RTV) at 400/400 mg (arm B)
Trial: 8018144
Drug: Zidovudine therapy
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine therapy
Trial: 31107775
Drug: Nurse-led cognitive
RxNorm normalized name: PAD,NURSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led cognitive behavioral intervention (five monthly in-home sessions and telephone consultations)
Trial: 23351824
Drug: n-3 PUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA 1 g/daily
Trial: 21283919
Drug: Cetaphil UVA/UVB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetaphil UVA/UVB Defense SPF 50 sunscreen exposed to natural sunlight (4 doses ranging from 2–6 MED)
Trial: 17966178
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IPL (580-980 nm) and bipolar radiofrequency (RF) energies
Trial: 7906386
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg of zidovudine per day
Trial: 7906386
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of zidovudine per day
Trial: 25803346
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy alone (medical group; n=53)
Trial: 17223985
Drug: Tibolone at
RxNorm normalized name: TIBOLONE
DrugBank: Tibolone (DB09070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone at a dose of 2.5‐7.5 mg/day
Trial: 9555445
Drug: Self-applied breathing
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-applied breathing and guided imagery relaxation techniques, separately and in combination, and a reinforcement tool
Trial: 31268131
Drug: TRF plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRF plus 3 g/d HMB (TRFHMB)
Trial: 25449504
Drug: 4.5 mg
RxNorm normalized name: phenol 14.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 mg adenosine (ADO)
Trial: 23575051
Drug: Oral Tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Tranexamic Acid (250 mg twice a day for three months)
Trial: 23575051
Drug: Routine topical
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine topical therapies
Trial: 17311685
Drug: Educational intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Educational intervention using postcards and posters on depression and its treatment
Trial: 9543445
Drug: gp160 in
RxNorm normalized name: Gp160 Vaccine
DrugBank: VaxSyn (DB17827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gp160 in alum over a 2‐year period in combination with zidovudine (n = 34)
Trial: 9543445
Drug: alum over
RxNorm normalized name: alum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alum over a 2‐year period in combination with zidovudine (n = 33)
Trial: 3143277
Drug: Urapidil (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil (60 mg orally thrice a day)
Trial: 20528706
Drug: Stepped care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped care model (including watchful waiting, guided self-help, brief psychotherapy, longer-term psychotherapy, and antidepressant medication)
Trial: 20528706
Drug: Longer-term face-to-face
RxNorm normalized name: FACE SHIELD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Longer-term face-to-face psychotherapy and antidepressant medication
Trial: 12648863
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (4.0 g loading dose over 30 min, followed by 1-2 g/hour continuous infusion for up to 21 days)
Trial: 3529153
Drug: Verapamil (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (calcium antagonist) at doses of 320-480 mg/day
Trial: 17493509
Drug: M. charantia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M. charantia capsules (two capsules three times a day after meals for 3 months)
Trial: 17493509
Drug: Placebo (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (two capsules three times a day after meals for 3 months)
Trial: 17493509
Drug: M. charantia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M. charantia capsules
Trial: 21327805
Drug: Midazolam 0.5
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.5 mg/kg
Trial: 3081928
Drug: Diazepam 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.3 mg/kg
Trial: 8543748
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of furosemide
Trial: 8543748
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of furosemide
Trial: 2720135
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg nitrofurantoin tablet
Trial: 794000
Drug: Indoprofen 600
RxNorm normalized name: Neoprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indoprofen 600 mg daily for 7 days
Trial: 794000
Drug: Ibuprofen 900
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 900 mg daily for 7 days
Trial: 31474439
Drug: Pegcetacoplan monthly
RxNorm normalized name: Pegcetacoplan
DrugBank: Pegcetacoplan (DB16694)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pegcetacoplan monthly
Trial: 31624047
Drug: CVD treatment
RxNorm normalized name: Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD treatment (cyclophosphamide, bortezomib, and dexamethasone)
Trial: 16498057
Drug: Rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (4 mg daily for 12 weeks)
Trial: 8299662
Drug: CL284,846 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CL284,846 (20 mg)
Trial: 9888613
Drug: Lorazepam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (2 mg)
Trial: 24980392
Drug: DX-2930 (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DX-2930 (0.3 mg/kg)
Trial: 24980392
Drug: DX-2930 (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DX-2930 (1.0 mg/kg)
Trial: 24980392
Drug: DX-2930 (3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DX-2930 (3.0 mg/kg)
Trial: 20525230
Drug: Twice the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice the recommended dietary allowance of 14 micronutrients for 6 months
Trial: 20525230
Drug: Twice the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice the recommended dietary allowance of 14 micronutrients in ART stratum
Trial: 20525230
Drug: Twice the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice the recommended dietary allowance of 14 micronutrients in non-ART stratum
Trial: 1830266
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of EE2
Trial: 6124671
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g methylprednisolone
Trial: 19786940
Drug: Half-dose reteplase
RxNorm normalized name: reteplase
DrugBank: Reteplase (DB00015)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Half-dose reteplase (r-PA) plus abciximab
Trial: 10087431
Drug: Early introduction
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early introduction of fluindione (20 mg once daily starting on day 1)
Trial: 10087431
Drug: Delayed introduction
RxNorm normalized name: INTRODUCTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed introduction of fluindione (20 mg once daily starting on day 10)
Trial: 21537337
Drug: Transdermal nitroglycerine
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerine treatment (1.25 mg patch for 6 months)
Trial: 16894240
Drug: Thiazolidinediones (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazolidinediones (in vitro treatment of 3T3 F442A adipocytes)
Trial: 12953340
Drug: Double-strength grapefruit
RxNorm normalized name: GRAPEFRUIT
DrugBank: Grapefruit (DB10534)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-strength grapefruit juice (DS GFJ) 240 mL tid for 3 days
Trial: 12953340
Drug: Single-strength grapefruit
RxNorm normalized name: GRAPEFRUIT
DrugBank: Grapefruit (DB10534)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-strength grapefruit juice (SS GFJ) 240 mL
Trial: 1513726
Drug: Nebulized albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized albuterol (0.15 mg/kg)
Trial: 6475060
Drug: Moderately high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately high-dose methotrexate (MTX) 250 mg/m2 to 750 mg/m2 at 10-day intervals
Trial: 6475060
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (MTX) 5 to 15 g at 10-day intervals
Trial: 6475060
Drug: Ultra-high therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-high therapy with a cumulative dose of 205 g MTX
Trial: 6475060
Drug: Two cases
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two cases of severe malignant non-Hodgkin's lymphoma treated with MTX (1 patient received 2 X 1 g MTX, the other received a single dose of 5 g MTX)
Trial: 30592476
Drug: Intranasal ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal ketamine (1.5 mg/kg)
Trial: 29287863
Drug: Intranasal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal fentanyl (1.5 mcg/kg)
Trial: 29287863
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol (10 mg/kg)
Trial: 23411886
Drug: Dexamethasone intravitreal
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone intravitreal implant
Trial: 24612095
Drug: Bevacizumab injections
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab injections
Trial: 23019837
Drug: Oral Midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral Midazolam (0.5 mg/kg)
Trial: 23019837
Drug: Intravenous Midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous Midazolam (0.06 mg/kg)
Trial: 23855176
Drug: Oral Placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Placebo
Trial: 2506337
Drug: Alcohol (0.694
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.694 g of alcohol per kg b.wt.)
Trial: 27798224
Drug: Amphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amphetamine (10 mg)
Trial: 6548392
Drug: Commercial oral
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercial oral elixir of theophylline
Trial: 6548392
Drug: Rectal suppository
RxNorm normalized name: Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal suppository of aminophylline
Trial: 6548392
Drug: Rectal enema
RxNorm normalized name: Fleet Rectal Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal enema of theophylline monoethanolamine
Trial: 30176671
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg WP-0508ST
Trial: 30176671
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg WP-0508ST
Trial: 24939916
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual control (n = 101)
Trial: 10350027
Drug: Amisulpride 400
RxNorm normalized name: amisulpride 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride 400 mg
Trial: 7548709
Drug: Two-stage sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-stage sequential design with variance-based weights for treatment effects
Trial: 26643240
Drug: Fondaparinux sodium,
RxNorm normalized name: Fondaparinux Sodium, 5 mg/0.4 mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux sodium, 2.5 mg, 1/d for 11 d
Trial: 17653532
Drug: Mirtazapine (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (7.5 mg)
Trial: 16497273
Drug: Mirtazapine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (15 mg)
Trial: 15853576
Drug: Natalizumab (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natalizumab (300 mg intravenous infusion, administered monthly)
Trial: 29171139
Drug: linagliptin 5
RxNorm normalized name: linagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: linagliptin 5 mg
Trial: 23507346
Drug: Pelvic fitness
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic fitness program (6-week duration, twice a week)
Trial: 14609611
Drug: Physiologic testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physiologic testosterone therapy
Trial: 18092150
Drug: Terlipressin (TP)
DrugBank: Terlipressin (DB02638)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (TP) administered as intravenous bolus doses of 20 microg/kg every 6 h for a maximum of 96 h
Trial: 10683715
Drug: Diclofenac potassium
RxNorm normalized name: Diclofenac Potassium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac potassium salt 50 mg in sachet (Voltfast)
Trial: 8229120
Drug: IL-3 at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-3 at doses > or = 2.5 micrograms/kg
Trial: 25236397
Drug: Smaller pouch
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Smaller pouch size group (10-20 ml)
Trial: 21669298
Drug: Hydroxychloroquine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine therapy for newly diagnosed extensive cGVHD
Trial: 12850361
Drug: RSV PFP-2
RxNorm normalized name: RSV-IGIV
DrugBank: Respigam (DB17765)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSV PFP-2 vaccine
Trial: 8724922
Drug: 6% glucose/sucrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% glucose/sucrose solution at the rate of 0.6 g.kg‐1 (Body Weight).hr.‐1
Trial: 11486115
Drug: Concurrent controls
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent controls (9 patients)
Trial: 8651473
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium 1% nasal spray QID + astemizole
Trial: 8651473
Drug: Placebo nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nasal spray + astemizole
Trial: 8651473
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (nedocromil sodium + astemizole)
Trial: 1347103
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg lovastatin daily
Trial: 1347103
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg lovastatin daily
Trial: 6734045
Drug: Nifedipine (18.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (18.5 +/- 4 mg every 8 hr)
Trial: 31903334
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) only, 50 mg/kg administered intravenously before surgery
Trial: 31903334
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid combined with vitamin C (TXC), 50 mg/kg TA and 2 g vitamin C with 100 mL 0.9% saline administered before surgery and daily infusions post-operation
Trial: 24086333
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral Tenofovir/Emtricitabine (TDF/FTC‐Truvada)
Trial: 24086333
Drug: Intermittent oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent oral Tenofovir/Emtricitabine (TDF/FTC)
Trial: 24086333
Drug: Post‐coital dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post‐coital dosing of Tenofovir/Emtricitabine (TDF/FTC)
Trial: 17110217
Drug: Dutasteride 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 2.5 mg
Trial: 3123091
Drug: Intravenous rt-PA
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous rt-PA (50 mg over 2 hr)
Trial: 3123091
Drug: Intrapulmonary rt-PA
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrapulmonary rt-PA (50 mg over 2 hr)
Trial: 3123091
Drug: Intrapulmonary rt-PA
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrapulmonary rt-PA (100 mg over 5 hr)
Trial: 3123091
Drug: Intravenous rt-PA
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous rt-PA (100 mg over 5 hr)
Trial: 3123091
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Intravenous and Intrapulmonary rt-PA)
Trial: 29899061
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch (21 mg) for four weeks before quitting
Trial: 29899061
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard smoking cessation pharmacotherapy and behavioral support)
Trial: 27583380
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide alone
Trial: 19236622
Drug: Blood glucose
RxNorm normalized name: Blood Glucose Book
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood glucose <= 8.0 mmol/l
Trial: 16551889
Drug: Antithrombin (3000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithrombin (3000 U infused over 30 min before heparin administration and 24 h later)
Trial: 16551889
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no antithrombin infusion)
Trial: 9376645
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg melatonin at 20:00 h on Days 1 to 15 (Melatonin 1st)
Trial: 7902484
Drug: Pamidronate therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate therapy (180 or 360 mg during 6 or 9 weeks)
Trial: 7902484
Drug: Pamidronate therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate therapy (45 mg every 3 months for 1 year)
Trial: 28386783
Drug: Dexamethasone, total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone, total dose of 30 mg perioperatively
Trial: 23596788
Drug: Modified Taohe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Taohe Chengqi Granule (MTCG) combined with intravenous dripping of mannitol
Trial: 23596788
Drug: Intravenous dripping
RxNorm normalized name: DRIP COLLECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dripping of mannitol alone
Trial: 17192498
Drug: Fasudil HCl
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Fasudil (DB08162)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Fasudil HCl administered as solution to the ascending colon
Trial: 17192498
Drug: Fasudil HCl
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Fasudil (DB08162)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Fasudil HCl administered as powder to the ascending colon
Trial: 17192498
Drug: Fasudil HCl
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Fasudil (DB08162)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Fasudil HCl administered orally as an immediate-release tablet
Trial: 2929903
Drug: Lignocaine 1
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine 1 mg/kg
Trial: 25954849
Drug: Individualized heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized heparin management (IHM)
Trial: 23962470
Drug: Intrathecal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal fentanyl 10 μg
Trial: 21372608
Drug: Metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin + lifestyle (ML)
Trial: 29546579
Drug: Metformin (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (in vitro)
Trial: 17135672
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of LPS + BGL
Trial: 8827547
Drug: Artificial surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial surfactant therapy for hyaline membrane disease (HMD)